Weiping Deng Selected Research

Weiping Deng Research Topics

Disease

18	COVID-19 03/2024 - 01/2021
8	Neoplasms (Cancer) 03/2024 - 12/2008
5	Infections 12/2022 - 08/2012
3	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 10/2016
3	Chronic Hepatitis C 04/2014 - 08/2012
2	Non-alcoholic Fatty Liver Disease 01/2015 - 11/2013
2	Liver Diseases (Liver Disease) 01/2015 - 10/2010
2	Anemia 11/2013 - 11/2010
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2024
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Myocarditis (Carditis) 01/2022
1	COVID-19 related pediatric multisystem inflammatory disease 01/2022
1	Pericarditis 01/2022
1	Fatigue 12/2021
1	Headache (Headaches) 12/2021
1	Pain (Aches) 12/2021
1	Asymptomatic Infections 11/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Myocardial Infarction 01/2020
1	Hemorrhage 09/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2018
1	Neoplasm Metastasis (Metastasis) 06/2017
1	Hepatitis B 01/2017
1	Vitamin D Deficiency 01/2017
1	Microcephaly 11/2016
1	Colorectal Neoplasms (Colorectal Cancer) 04/2015
1	Body Weight (Weight, Body) 01/2015
1	Insulin Resistance 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 07/2013
1	Drug-Related Side Effects and Adverse Reactions 08/2012
1	Hepatitis C 08/2012
1	Esophageal Neoplasms (Esophageal Cancer) 07/2012
1	Hemolysis 11/2010
1	Colonic Neoplasms (Colon Cancer) 03/2009

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 03/2024 - 01/2021
13	2019-nCoV Vaccine mRNA-1273IBA 03/2024 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2008
4	Ribavirin (Virazole)FDA LinkGeneric 04/2014 - 11/2010
3	Neutralizing AntibodiesIBA 12/2023 - 08/2021
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2021
3	Histone Deacetylase InhibitorsIBA 04/2015 - 07/2011
3	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 04/2014 - 08/2012
2	N-(2-cyanoethylene)urea (BA 1)IBA 03/2024 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2023 - 08/2021
2	AntibodiesIBA 01/2023 - 01/2022
2	Liraglutide FDA Link 01/2015 - 11/2013
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2015 - 11/2013
1	mRNA VaccinesIBA 03/2024
1	mRNA-1273.214 COVID-19 vaccineIBA 03/2024
1	beta-solamarineIBA 03/2024
1	CalciumIBA 01/2024
1	A 17 (A-17)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	AcidsIBA 12/2022
1	Amino Acids FDA Link 12/2022
1	SugarsIBA 12/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Lipid NanoparticlesIBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 09/2019
1	nilotinib FDA Link 05/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	sodium-bile acid cotransporterIBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	LipidsIBA 01/2017
1	Sirtuin 1IBA 10/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2015
1	CholesterolIBA 01/2015
1	Erythropoietin FDA Link 11/2013
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2012
1	Verapamil (Calan)FDA LinkGeneric 07/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2012
1	Cisplatin (Platino)FDA LinkGeneric 07/2012
1	HematinicsIBA 11/2010
1	HesperidinIBA 10/2010
1	N- hydroxy- 3- (2- phenethyl- 1- (2- pyrrolidin- 1- yl- ethyl)- 1H- benzimidazol- 5- yl)acrylamideIBA 03/2009

Therapy/Procedure

3	Injections 12/2021 - 01/2021
3	Therapeutics 06/2017 - 08/2012
2	Intramuscular Injections 11/2021 - 01/2021
2	Drug Tapering 11/2013 - 11/2010
1	Radiotherapy 07/2012
1	Chemoradiotherapy 07/2012